Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine

ClinicalTrials.gov ID: NCT00000720

Public ClinicalTrials.gov record NCT00000720. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 6:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the clinical, immunologic, and virologic effects of oral zidovudine (AZT) plus intravenous immunoglobulin (IVIG) versus AZT plus placebo (albumin). It is estimated that by 1991, there may be 10,000 to 20,000 HIV-infected children in the United States. HIV infection in children is most often associated with symptomatic disease and poor prognosis. Treatment with antiviral therapy may be effective in changing the course of disease and decreasing mortality in this vulnerable population. AZT treatment has been shown to decrease mortality and the frequency of opportunistic infections in certain adult AIDS patients; therefore, it is likely that children may also benefit from this antiviral therapy. In addition, bacterial infections are frequently found in HIV-infected children. Because pooled human serum immunoglobulin, another name for antibodies, is effective in reducing bacterial infection in patients with defects of immunity, it may reduce the rate of bacterial infection in HIV-infected children as well. In this study, AZT will be administered together with IVIG to determine safety, tolerance, and efficacy of the combined treatment.

Study identification

NCT ID
NCT00000720
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
250 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
3 Months to 12 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Apr 1993 (Actual)
Last update posted
Nov 3, 2021

Ends 1993

United States locations

U.S. sites
48
U.S. states
16
U.S. cities
32
Facility City State ZIP Site status
Kaiser Permanente / UCLA Med Ctr Downey California 902422814 —
Long Beach Memorial (Pediatric) Long Beach California 90801 —
Children's Hosp of Los Angeles/UCLA Med Ctr Los Angeles California 900276016 —
Los Angeles County - USC Med Ctr Los Angeles California 90033 —
Cedars Sinai / UCLA Med Ctr Cedars-Sinai Medical Center Los Angeles California 900481804 —
Martin Luther King Jr Gen Hosp / UCLA Med Ctr Los Angeles California 900593019 —
UCLA Med Ctr / Pediatric Los Angeles California 900951752 —
Stanford Univ School of Medicine Menlo Park California 94025 —
Children's Hosp of Oakland Oakland California 946091809 —
Univ of California / San Diego Treatment Ctr San Diego California 921036325 —
Northern California Pediatric AIDS Treatment Ctr / UCSF San Francisco California 94143 —
Olive View Med Ctr Sylmar California 91342 —
Univ of Connecticut Health Ctr / Pediatrics Farmington Connecticut 06032 —
Emory Univ School of Medicine Atlanta Georgia 30303 —
Cook County Hosp Chicago Illinois 60612 —
Univ of Illinois College of Medicine Chicago Illinois 60612 —
Chicago Children's Memorial Hosp Chicago Illinois 606143394 —
Tulane Univ School of Medicine New Orleans Louisiana 70112 —
Univ of Maryland at Baltimore / Univ Med Ctr Baltimore Maryland 21201 —
Children's Hosp of Boston Boston Massachusetts 021155724 —
Boston Med Ctr Boston Massachusetts 02118 —
Univ of Massachusetts Med Ctr Worcester Massachusetts 01655 —
Univ of Minnesota Minneapolis Minnesota 55455 —
Children's Hosp of New Jersey / UMDNJ - New Jersey Med Schl Newark New Jersey 071072198 —
SUNY / Health Sciences Ctr at Brooklyn / Pediatrics Brooklyn New York 11203 —
City Hosp Ctr at Elmhurst / Mount Sinai Hosp Elmhurst New York 11373 —
Schneider Children's Hosp / Long Island Jewish Med Ctr New Hyde Park New York 11042 —
Beth Israel Med Ctr / Pediatrics New York New York 10003 —
Bellevue Hosp / New York Univ Med Ctr New York New York 10016 —
Saint Luke's - Roosevelt Hosp Ctr New York New York 10025 —
Metropolitan Hosp Ctr New York New York 10029 —
Mount Sinai Med Ctr New York New York 10029 —
Columbia Univ Babies' Hosp New York New York 10032 —
Harlem Hosp Ctr New York New York 10037 —
Univ of Rochester Medical Center Rochester New York 14642 —
Lincoln Hosp Ctr / Pediatrics The Bronx New York 10451 —
Albert Einstein College of Medicine The Bronx New York 10461 —
Westchester Hosp / New York Med College / Pediatrics Valhalla New York 10595 —
Duke Univ Med Ctr Durham North Carolina 277103499 —
Holmes Hosp / Univ of Cincinnati Med Ctr Cincinnati Ohio 452670405 —
Univ Hosp of Cleveland / Case Western Reserve Univ Cleveland Ohio 44106 —
Columbus Children's Hosp Columbus Ohio 432052696 —
Ohio State Univ Hosp Clinic Columbus Ohio 432101228 —
Saint Christopher's Hosp for Children Philadelphia Pennsylvania 191341095 —
Julio Arroyo West Columbia South Carolina 29169 —
Hermann Hosp / Univ Texas Health Science Ctr Houston Texas 77030 —
Texas Children's Hosp / Baylor Univ Houston Texas 77030 —
Children's Hosp of Seattle Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00000720, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 3, 2021 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00000720 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →